These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Methadone and intravenous morphine requirements. Treatment of pain due to advanced cancer. Kepes ER; Raj S; Thomas P; Vemulapalli K N Y State J Med; 1983 Jun; 83(7):925-7. PubMed ID: 6193466 [No Abstract] [Full Text] [Related]
45. [Spinal cord transection with absolute alcohol in the treatment of tumor pain]. RodrÃguez Alvarez E Rev Esp Anestesiol Reanim; 1987; 34(4):260-1. PubMed ID: 3477843 [No Abstract] [Full Text] [Related]
46. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. Ballantyne JC; Carr DB; Berkey CS; Chalmers TC; Mosteller F Reg Anesth; 1996; 21(6):542-56. PubMed ID: 8956391 [TBL] [Abstract][Full Text] [Related]
47. [Controlled study of the analgesic effect and tolerability of buprenorphine in cancer patients]. Dini D; Fassio T; Gottlieb A; Gini M Minerva Med; 1986 Jan; 77(3-4):93-104. PubMed ID: 3511410 [TBL] [Abstract][Full Text] [Related]
48. Methadone in the management of cancer pain: a review. Fainsinger R; Schoeller T; Bruera E Pain; 1993 Feb; 52(2):137-147. PubMed ID: 8455961 [TBL] [Abstract][Full Text] [Related]
49. Diclofenac does not modify methadone bioavailability in cancer patients. Bianchi M; Clavenna A; Groff L; Zecca E; Ripamonti C J Pain Symptom Manage; 1999 Apr; 17(4):227-9. PubMed ID: 10203873 [No Abstract] [Full Text] [Related]
52. State cancer pain initiatives. Dahl JL NIDA Res Monogr; 1993; 131():260-5. PubMed ID: 8413539 [No Abstract] [Full Text] [Related]
53. [Clinical trial of butorphanol tartrate in cancer patients: evaluation for analgesic effects and safety on the basis of long term administration]. Konno K; Nakai Y; Ebina A; Sato M; Nagai K; Hayashi I; Ito T Gan To Kagaku Ryoho; 1983 Jul; 10(7):1634-45. PubMed ID: 6347086 [TBL] [Abstract][Full Text] [Related]
55. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425 [TBL] [Abstract][Full Text] [Related]
56. Brompton's solution: regime for chronic pain relief. Tanner JA ONA J; 1978 Mar; 5(3):73-4. PubMed ID: 246507 [No Abstract] [Full Text] [Related]
57. The Brompton mixture. Culver-James J Can Med Assoc J; 1979 Jun; 120(11):1331. PubMed ID: 88250 [No Abstract] [Full Text] [Related]
58. Nursing grand rounds. Achieving pain control in the patient with multiple myeloma: a team approach. Nursing; 1979 Nov; 9(11):34-9. PubMed ID: 259195 [No Abstract] [Full Text] [Related]
59. Clinical evaluation of combined treatment with methadone and psychotropic drugs in cancer patients. Breivik H; Rennemo F Acta Anaesthesiol Scand Suppl; 1982; 74():135-40. PubMed ID: 6953727 [No Abstract] [Full Text] [Related]
60. Pharmacokinetic basis for optimal methadone treatment of pain in cancer patients. Paalzow L; Nilsson L; Stenberg P Acta Anaesthesiol Scand Suppl; 1982; 74():55-8. PubMed ID: 6953739 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]